Addendum: de Leve, S.; et al. The CD73/Ado System—A New Player in RT Induced Adverse Late Effects. Cancers 2019, 11, 1578

Documenti analoghi

• The CD73/Ado System—A New Player in RT Induced Adverse Late Effects
  di: de Leve, Simone, et al.
  Pubblicazione: (2019)
• Targeting the Immunomodulatory CD73/Adenosine System to Improve the Therapeutic Gain of Radiotherapy
  di: de Leve, Simone, et al.
  Pubblicazione: (2019)
• The Role of Lymphocytes in Radiotherapy-Induced Adverse Late Effects in the Lung
  di: Wirsdörfer, Florian, et al.
  Pubblicazione: (2016)
• Combining Radiotherapy and Immunotherapy in Lung Cancer: Can We Expect Limitations Due to Altered Normal Tissue Toxicity?
  di: Wirsdörfer, Florian, et al.
  Pubblicazione: (2018)
• Modeling DNA damage-induced pneumopathy in mice: insight from danger signaling cascades
  di: Wirsdörfer, Florian, et al.
  Pubblicazione: (2017)